Pfizer PFE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.2B+8.1% | $1.11B-62.1% | $2.92B+523% | $468M-76.4% | ||
| $12.45B-35.9% | $19.43B+97.6% | $9.84B-55.9% | $22.32B-23.4% | ||
| $11.87B+3.6% | $11.46B-0.9% | $11.57B+5.6% | $10.95B-4.6% | ||
| $2.37B-11.0% | $2.66B-41.7% | $4.57B-21.6% | $5.83B+521% | ||
| $42.9B-14.8% | $50.36B+16.2% | $43.33B-15.5% | $51.26B-14.1% | ||
| $19.32B+5.0% | $18.39B-2.9% | $18.94B+16.4% | $16.27B+9.4% | ||
| $71.26B+4.0% | $68.53B+1.1% | $67.78B+31.9% | $51.38B+4.4% | ||
| $208.16B-2.5% | $213.4B-5.8% | $226.5B+14.9% | $197.21B+8.7% | ||
| $5.24B-7.0% | $5.63B-16.1% | $6.71B-1.5% | $6.81B+22.1% | ||
| $3B-20.0% | $3.75B+66.2% | $2.25B-12.0% | $2.56B+56.5% | ||
| $36.98B-14.0% | $43B-10.0% | $47.79B+13.4% | $42.14B-1.2% | ||
| $61.64B+7.4% | $57.41B-6.7% | $61.54B+87.1% | $32.88B-9.1% | ||
| $3.25B-97.4% | $124.9B-9.0% | $137.21B+35.5% | $101.29B-2.6% | ||
| $114.61B-1.8% | $116.73B-1.4% | $118.35B-5.8% | $125.66B+21.5% | ||
| $86.48B-2.0% | $88.2B-0.9% | $89.01B-6.9% | $95.66B+23.9% | ||
| $208.16B-2.5% | $213.4B-5.8% | $226.5B+14.9% | $197.21B+8.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pfizer's total assets?
- Pfizer (PFE) holds $207.62B in total assets, down 0.2% year over year.
- How much debt does Pfizer have?
- Pfizer carries $64.4B in total debt against $90.1B of shareholders' equity, a debt-to-equity ratio of 0.71.
- How much cash does Pfizer have?
- Pfizer holds $1.8B in cash and equivalents.
- Can Pfizer cover its short-term obligations?
- Its current ratio is 1.25 — current assets exceed current liabilities.
- Where does Pfizer's balance sheet data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
